UK News Britain FINALLY approves Pfizer's 'life-saving' Covid pill
Business leaders in Northern Ireland condemn new Covid restrictions
The move to close nightclubs was agreed at a virtual meeting of the powersharing Executive, in which it was determined that dancing will also be prohibited in hospitality venues . It will not apply to weddings, however.First Minister Paul Givan described the measures as 'proportionate based on where we are today' but added they will be kept under review.However, Belfast Chamber of Commerce heavily criticised the fact that no additional financial support package was agreed to accompany the measures.
Britain today finally approved a 'life-saving' antiviral Covid pill that can be taken by vulnerable people at home.
Paxlovid, made by vaccine giant, was given the green light by the Medicines and Healthcare products Regulatory Agency (MHRA).
It will be doled out to adults who could be vulnerable to the virus due to their age, weight or a prior chronic illness.
The UK has also bumped its original order of the drug to 2.75million courses, after commentators criticised ministers for initially only ordering 250,000.
While the commercial agreement between Pfizer and the UK is confidential, health chiefs in America are reported to have paid the equivalent of £390 for each of the 10million courses it ordered.
live Covid-19: In Paris, the restaurants threatened by the absence of tourists
© a jarry-triplon / onlyfrance.f picture of illustration, in Montmartre, on December 2nd. In summary: - The number of contaminations reaches a record in France. More than 90,000 new cases of COVID-19 were recorded Thursday over the last twenty-four hours, a level never reached since the beginning of the pandemic. - In Europe, Restrictions are multiplying : the show rooms close from Sunday in Belgium while the outdoor mask is back in Spain and Italy.
If applied to the UK, it would mean No10 has spent in the region of £1billion to buy supplies.
While Paxlovid had promising results in trials it is unknown how the antiviral works against Omicron. The MHRA said it was working with Pfizer to establish if it is less effective.
Details on how the drug will be distributed in the UK such as which groups will be prioritised, and when exactly it will be available for use, are yet to be revealed.
HOW DOES PFIZER'S PILL WORK?
What is it?
COVID-19 in Senegal: Riposte, Third dose and vaccination of children in question
© AP - LEO Correa A caregiver member administers a dose of the Janssen vaccine against Cvid-19 at the Dakar Leopold-Sedar-Senghor Staded On July 28, 2021. Senegal is "in the 4th wave" of COVID-19: the Ministry of Health confirms. The country recorded, Wednesday, December 29, 156 new infections, compared to 2 new daily cases on average in November. The Dakar region remains the most affected.
Pfizer's drug is part of a class known as protease inhibitors.
It is designed to block an enzyme the coronavirus needs in order to multiply.
Like protease inhibitors used to treat HIV, it is given in combination with other antivirals.
How effective is it?
A recent trial of the pill in more than 2,200 adults found that it cut hospitalisation and death rates by 89 per cent in people at high risk of a severe illness from Covid.
It also cut the risk of being admitted to hospital and dying by 70 per cent among healthy unvaccinated people and vaccinated adults with one or more underlying illnesses.
It should be given as soon as possible after catching Covid, ideally within three to five days.
How much has the UK ordered?
The decision to approve Paxlovid for use in the UK came after the MHRA found the drug – which can be taken at home – was safe and effective at reducing the risks of being admitted to hospital and death in people with mild to moderate infection and who are also at an increased risk of developing severe disease.
A fourth dose of anti-covid vaccine in the gout-record in Israel
© Ammar Awad, Reuters A man is vaccinated against CIVID-19 in a commercial center of Jerusalem, December 22, 2021. The fourth dose of vaccine For immunocompromised persons, but not at this stage for other categories of the population. Israeli hospitals equip the new Pfizer's anti-Covid drug that is considered a strategic element of the fight against the Omicron variant. with our correspondent in Jerusalem, Michel Paul An fourth dose to the gout.
In a clinical trial in high-risk adults with symptomatic illness, it was found to reduce the risk of being admitted to hospital and of death by almost 90 per cent.
Health Secretary Sajid Javid said: 'The UK has been a world leader at finding and rolling out Covid treatments to patients.
'This is further proved by the MHRA being one of the first in the world to approve this life-saving antiviral.
'We are also leading the whole of Europe in the number of antivirals we’ve bought per person – with over 2.75million courses of this antiviral secured for NHS patients by the Antivirals Taskforce.
'The booster campaign, testing and antiviral defences ensure our country is in the strongest possible position to deal with the threat posed by Omicron as we head into the new year.'
Video: COVID-19 Pills May Conflict With Certain Medications, Study Finds (Cover Video)
Developed by Pfizer, Paxlovid is an antiviral medicine with a combination of active ingredients, PF-07321332 and ritonavir, that works by inhibiting a protease required for virus replication.
31 of the most embarrassing Brexit moments from the UK’s first year outside the EU
31 of the most embarrassing Brexit moments from the UK’s first year outside the EU -Not everything that was predicted in project fear came to pass but in many ways, it might as well have.
This prevents Covid from multiplying, keeping virus levels low and helping the body to overcome the viral infection.
The two active substances of Paxlovid come as separate tablets that are packaged together and taken together, twice a day by mouth for five days.
Dr June Raine, MHRA chief executive, said: 'Today we have given our regulatory approval for Paxlovid, a Covid treatment found to cut Covid related hospitalisations and deaths by 89 per cent when taken within three days of the start of symptoms.
'We now have a further antiviral medicine for the treatment of Covid that can be taken by mouth rather than administered intravenously.
'This means it can be administered outside a hospital setting, before Covid has progressed to a severe stage.
'I hope the announcement today gives reassurance to those particularly vulnerable to Covid, for whom this treatment has been approved. For these individuals, this treatment could be life-saving.'
Based on the clinical trial data, MHRA said it had found Paxlovid is most effective when taken during the early stages of infection and so recommends its use as soon as possible and within five days of the start of symptoms.
More than 2MILLION people in England had Covid just before Xmas
More than 2million people in England had Covid just before Christmas, official surveillance data suggested today amid warning signs that infections are now rising quickest in over-65s.
COVID-19: fewer deaths, but mostly affects the mortality due to COVID-19 has fallen sharply since the first two epidemic waves, thanks to the progress made in the treatment of patients and the vaccination. People over 70 and non-vaccinated remain the fir
If the media no longer do the daily count of the deaths due to COVID-19 , the disease continues to make victims. However, deaths are numerous than at the beginning of the pandemic. Indeed, during the first wave of COVID-19, France France has identified up to 500 deaths per day of the virus, and 400 during the second wave. During the summer of 2021, the figures of the epidemic fell down to the lowest, with about fifteen COVID dead per day.
The Office for National Statistics' (ONS) weekly report estimated one in 25 people had the virus on December 23, marking a 70 per cent surge in a week and the highest toll seen throughout the entire pandemic.
Covid is most prevalent in Omicron epicentre, where one in 15 people were estimated to be infected over the festive period, followed by the South East and East of England at one in 30.
The ONS analysis is based on random swab testing of tens of thousands of people across Britain and the results are inspected closely by ministers. But it only offers a glimpse of how widespread the virus is, meaning it won't reveal whether cases have truly peaked in London, like official data suggests, for another few weeks.
Separate Government statistics showed infections are now rising fastest and doubling every week among over-65s — the age group most vulnerable to the virus.
Experts today warned this would 'directly feed' into hospitalisations over the coming weeks and that a spike was 'certain'. But they added that the booster drive, which has already reached 90 per cent of older adults, will give millions an extra layer of protection and help the NHS this winter.
It has been authorised for use in people aged 18 and above who have mild to moderate Covid infection and at least one risk factor for developing severe illness.
Such risk factors include obesity, being over 60, diabetes mellitus, or heart disease.
Ben Osborn, country manager at Pfizer UK, said: 'This milestone is an important moment in our continued fight against Covid, offering the NHS another possible treatment option as cases continue to rise.
Hospitals 'are crippled' by 14-day isolation rule for patients
Experts warned that hospitals were being 'crippled' by the rules, which force patients into two weeks of quarantine even if they are only a close contact of a Covid sufferer. Currently, most people have to isolate for as little as seven days if they test positive for Covid. If they are a close contact of someone with the virus, they no longer need to isolate at all if they are fully vaccinated.But in hospital any patient who tests positive – or who comes into close contact with a confirmed case – has to be treated in isolation for 14 days. They have to remain in quarantine even if they later test negative.
'This at-home therapy, shown in clinical trials to reduce hospitalisations and save lives, has the potential to lessen the devastating impact of a virus that has now taken over five million lives globally.'
Critics previously accused No10 of being 'asleep at the wheel' in its small order of Paxlovid, when considering the huge efforts that went into procuring Covid jabs.
Lord Bilimoria, president of the Confederation of British Industry (CBI), told theearlier this month that he had been lobbying ministers for months to secure millions more courses of antiviral drugs for the British public.
'We need every GP in the country to have a stock of these tablets. The moment somebody older tests positive, they go to their GP, and they take the tablets for five days. This should be our second line of defence behind vaccines,' he said at the time.
'We're talking about saving our economy hundreds of billions of pounds from endless Covid disruption. It’s a no brainer.
The MHRA has already approved another antiviral treatment called molnupiravir, sold by drug firm Merck and branded as Lagevrio.
This month Merck revealed their pill was just 30 per cent effective at reducing the risk of hospitalisation and death among the vulnerable, lower than earlier estimates.
The UK has already ordered 480,000 courses of molnupiravir which are already being offered to more than 1million Britons at serious risk of becoming severely ill with Covid, like cancer patients on chemotherapy.
Medical Desert: How to make access to care near a new French? .
© Thierry Zoccolan / AFP Nearly French French currently lives in a medical desert, with great difficulty access to care. This is the case of many rural departments, like the Gers. Here, general practitioners are salaried in the most voltage areas. Europe 1 went to a small town feared to become a medical desert. There remains only two general doctors in the small town of Gondrin, in the Gers. They are overwhelmed and both the age of retirement. An inhabitant, Danièle, do not know who go see.